Skip to content

Assessment of laser effect in treatment of women with vuluvaginal atrophy

Assessment of fractional co2 laser effect in treatment of women with vuluvaginal atrophy in Emam Khomeini hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171004036562N2
Enrollment
35
Registered
2020-06-11
Start date
2017-06-22
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy of the vagina. Postmenopausal atrophic vaginitis

Interventions

Intervention group: The intervention group uses fractional carbon dioxide laser, which is used in 3 sessions and 4 weeks apart..

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: one or more symptoms of VVA (e.g., vaginal discharge, itching, dyspareunia, dryness and urge urinary incontinence). no menstruation for = 12 months. not using local or systemic estrogen therapy. wishing to be sexual active.

Exclusion criteria

Exclusion criteria: : use of hormone replacement therapy (systemic or local) up to 6 month before entry to the study. pelvic organ prolapse stage > 2 (according to POP-Q system). active genital infections. acute or recurrent urinary tract infection. use of any vaginal lubricants. moisturizers or local preparations within 30 days before entry to the study. psychiatric disorders which could interfere with informed consent. any chronic disease that could interfere with study compliance. abnormal uterine bleeding which has no exact diagnosis. malignancies of urogenital.

Design outcomes

Primary

MeasureTime frame
The percentage of women who have vaginal dryness. Timepoint: The time intervals for assessing the vaginal dryness before the start of the laser and then one month two months and three months and one year after the laser is done. Method of measurement: questionnaire.;Percentage of women who have urinary incontinence. Timepoint: The time intervals for assessing the vaginal dryness before the start of the laser and then one month two months and three months and one year after the laser is done. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Dysuria together. Timepoint: The time intervals for assessing the vaginal dryness before the start of the laser and then one month two months and three months and one year after the laser is done. Method of measurement: questionnaire.;Vaginal itching accompanied. Timepoint: The time intervals for assessing the vaginal dryness before the start of the laser and then one month two months and three months and one year after the laser is done. Method of measurement: questionnaire.;Vaginal discharge accompanied. Timepoint: The time intervals for assessing the vaginal dryness before the start of the laser and then one month two months and three months and one year after the laser is done. Method of measurement: questionnaire.;Dyspareunia. Timepoint: The time intervals for assessing the vaginal dryness before the start of the laser and then one month two months and three months and one year after the laser is done. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Safa Al-Asiri

Tehran University of Medical Sciences

safaalasiri99@gmail+98 21 4459 8320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026